Changing Paradigm of First Line Therapy in Locally Advanced Metastatic Bladder Cancer
Parminder Singh, MD, explores the evolving treatment for bladder cancer, emphasizing advancements over the past decade.
Read MoreSelect Page
Posted by Parminder Singh, MD | Feb 2025
Parminder Singh, MD, explores the evolving treatment for bladder cancer, emphasizing advancements over the past decade.
Read MorePosted by Mitchell R. Humphreys, MD | Feb 2025
Mitchell R. Humphreys, MD, MPH, delves into benign prostatic hyperplasia management and holmium laser enucleation (HoLEP).
Read MorePosted by Daniel P. Petrylak, MD | Feb 2025
Daniel P. Petrylak, MD, analyzes bladder cancer treatment advancements, emphasizing recent clinical practice breakthroughs and challenges.
Read MorePosted by Nelson N. Stone, MD | Feb 2025
Nelson N. Stone, MD, balances the radiation dose and hormonal therapy in managing intermediate- and high-risk prostate cancer.
Read MorePosted by Juan H. Chipollini, MD, FACS | Feb 2025
Juan H. Chipollini, MD, FACS, provides an in-depth analysis of bladder-preserving approaches for muscle-invasive bladder cancer (MIBC).
Read More